Ventures
Invest in breakthrough healthtech solutions that transform patients' lives.
![](https://cdn.prod.website-files.com/664356b5a2e4f1e357ace733/664e0deb8695392b24a8b06f_hero-ventures.webp)
Receive the latest investment opportunities that match your interests, directly in your inbox. Stay informed and never miss out.
a highlight from our portfolio
![Angiogenesis Analytics](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/6655ac7331db4c9b8af53beb_elen-sher-qrTdlfGDRdI-unsplash.webp)
Angiogenesis Analytics
![PEP Health](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f42b62a54ca73b6086c6f_stephen-dawson-qwtCeJ5cLYs-unsplash.webp)
PEP Health
Heat2Move offers a revolutionizing approach to chronic back pain treatment. Unlike traditional methods relying on medications or heat patches, Heat2Move combines blue light and infrared warmth to enhance blood flow and muscle repair. This innovative solution provides therapists and patients with a new tool for managing chronic pain effectively. With its potential to make a significant impact on treatment options, BlueTouch offers hope for those suffering from back pain worldwide.
![Heat2move](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66544c20be6db09be405c0a0_6650568dde8ac83e564c4f10_heat%2520to%2520move.webp)
Persuasive addresses the challenge of identifying Stable Angina patients early on, crucial for preventing heart attacks. Currently, without a diagnostic test in general practitioner settings, many referrals to hospitals prove unnecessary. The solution is a simple blood test, leveraging an extracellular vesicle protein signature to distinguish SA patients from those with non-cardiac chest pain. This innovative approach promises to streamline patient management, saving lives and healthcare resources.
![Persuasive](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66544c22693b215a4d142e71_66505e6774ca8059daf91f2a_persuasive.webp)
Lumabs introduces a revolutionary diagnostic platform offering quick and precise biomolecule measurement right at the point of care. By eliminating the need for time-consuming laboratory processes, such as ELISA tests, Lumabs ensures patients receive vital diagnostic results immediately. This innovation is crucial in emergency and intensive care settings, where real-time information can guide rapid treatment decisions, potentially saving lives.
![Lumabs](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66544c215aea1f2595cd002f_66505ec1bdb05f752299ea64_lumabs.webp)
NLC's venture, Profionics, advances Cardiff University's sepsis research with a biomarker test combining AI, gene expression, and metabolic analysis for rapid, accurate diagnosis. This test, which works in under 30 minutes with a drop of blood, surpasses traditional methods by quickly identifying those needing antibiotics and reducing unnecessary use, thus combating antimicrobial resistance and saving lives. Particularly impactful in neonatal care, it ensures timely detection critical for newborn survival. Founded by NLC, Cardiff University, and CEO Darren Fergus, Profionics leverages extensive research and a blood sample BioBank, positioning itself as a leader in host response diagnostic testing.
![Profionics](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66714a926117c55b4250b91d_profionics.webp)
Symbio Therapy uses computer assisted tasks to improve rehabilitation after injury or illness. It is a platform where therapists can create customized exercises for patients to perform using special equipment connected to a tablet or computer. This allows patients to do their exercises at home, while therapists can monitor remotely. With elements of gaming, Symbio Therapy motivates patients to engage more actively in their therapy, leading to better results at lower costs. It's already being used successfully in multiple rehabilitation clinics.
![Symbio Therapy](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66544c23209c83fa19718ed5_664f539480668740cf23aaca_Symbio-_1_.webp)
Pasithea improves treating obstructive sleep apnea (OSA), a condition affecting millions worldwide. Traditional treatments like continuous positive airway pressure (CPAP) face high refusal and dropout rates. Pasithea offers a non-invasive solution based on triggered kinesthetic stimulation. By detecting early signs of apnea or hypopnea and inducing a controlled response, Pasithea activates muscle control centers to prevent oxygen desaturation and associated cardiovascular risks, aiming to improve patient compliance and outcomes.
![Pasithea](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/6655eddf7cd190f98abe4b90_pexels-ketut-subiyanto-4473863.webp)
MLA Diagnostics improves melanoma diagnosis, offering personalized measurement of malignancy levels. Traditional diagnosis often leads to overtreatment or undertreatment, resulting in patient distress or undetected cancer progression. By analyzing methylation, our test provides accurate prognosis, enabling tailored treatment plans and saving lives. With the melanoma therapeutics market on the rise, our innovative solution is poised to make a significant impact, improve patient outcomes and create opportunities.
![MLA Diagnostics](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/6655ac3e0291077cfc0507a3_angelica-echeverry-5KY5LP_zc44-unsplash.webp)
CareBed introduces a solution to empower individuals recovering from surgery or seeking home treatment: the world's first full vertical transfer sleep-to-stand electric bed. By positioning the patient in a straight-up posture with aligned gravity, CareBed enhances well-being and reduces reliance on unusable devices like patient lifting hoists. Healthcare workers benefit from a safer and more efficient patient transfer method, while institutions enjoy cost reductions due to faster transfers and reduced need for registered nurse assistance.
![Carebed](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66544c1f329a4fd7a6b15ad5_664f564c7d467dbbd63f2fb3_carebed.webp)
Our impact
Explore our 2023 Impact report
![Woman with hands in the air in nature](https://cdn.prod.website-files.com/664356b5a2e4f1e357ace733/6655f8079499fd8cf6aed6b7_oma3.webp)
Invest in a portfolio of companies
![A formal clothed man on a bridge in the city](https://cdn.prod.website-files.com/664356b5a2e4f1e357ace733/6652f74f2ec8d5aa5d579ba0_getty-images-PewCq3lCV0k-unsplash.webp)